TargetMol

Linezolid

Product Code:
 
TAR-T0391
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T0391-1mL1 mL * 10 mM (in DMSO)£101.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0391-10mg10mg£107.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0391-25mg25mg£139.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0391-50mg50mg£148.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0391-100mg100mg£189.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0391-200mg200mg£219.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Linezolid, the first of the oxazolidinone class, is a synthetic antibiotic used for the therapy of infections resulted from multi-resistant bacteria including methicillin-resistant Staphylococcus aureus (MRSA) and streptococcus. The drug takes effect as the inhibitor of the initiation of bacterial protein synthesis.
CAS:
165800-03-3
Formula:
C16H20FN3O4
Molecular Weight:
337.351
Pathway:
Metabolism; Microbiology/Virology; Neuroscience
Purity:
0.9999
SMILES:
CC(=O)NC[C@H]1CN(C(=O)O1)c1ccc(N2CCOCC2)c(F)c1
Target:
MAO; Antibacterial; Antibiotic

References

1. Swaney SM, et al. Antimicrob Agents Chemother, 1998, 42(12), 3251-3255. 2. Shinabarger DL, et al. Antimicrob Agents Chemother, 1997, 41(10), 2132-2136. 3. Noskin GA, et al. Antimicrob Agents Chemother, 1999, 43(8), 2059-2062. 4. Livermore DM, et al. J Antimicrob Chemother, 2003, 51 Suppl 2, ii9-16. 5. Alcal? L, et al. Antimicrob Agents Chemother, 2003, 47(1), 416-417.